The University of Chicago Header Logo

Connection

John Fung to Antiviral Agents

This is a "connection" page, showing publications John Fung has written about Antiviral Agents.
Connection Strength

0.589
  1. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl. 2002 Nov; 8(11):1007-13.
    View in: PubMed
    Score: 0.163
  2. The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. Transplantation. 2014 Jan 27; 97(2):e14-5.
    View in: PubMed
    Score: 0.089
  3. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl. 2009 Sep; 15(9):1003-6.
    View in: PubMed
    Score: 0.065
  4. Advances in hepatitis B virus infection. Transplant Proc. 2003 Feb; 35(1):342-4.
    View in: PubMed
    Score: 0.041
  5. Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci. 2002 Apr; 47(4):750-4.
    View in: PubMed
    Score: 0.039
  6. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
    View in: PubMed
    Score: 0.038
  7. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998 Jan 15; 65(1):82-6.
    View in: PubMed
    Score: 0.029
  8. Liver transplantation for hepatitis B: what have we learned and what does the future hold? Liver Transpl Surg. 1995 Jul; 1(4):274-80.
    View in: PubMed
    Score: 0.024
  9. Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Clin Transplant. 1995 Jun; 9(3 Pt 2):262-8.
    View in: PubMed
    Score: 0.024
  10. The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
    View in: PubMed
    Score: 0.019
  11. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
    View in: PubMed
    Score: 0.017
  12. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
    View in: PubMed
    Score: 0.010
  13. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation. 2000 Aug 15; 70(3):543-5.
    View in: PubMed
    Score: 0.009
  14. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
    View in: PubMed
    Score: 0.008
  15. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1998 Oct 27; 66(8):1047-52.
    View in: PubMed
    Score: 0.008
  16. Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. Gastroenterology. 1997 Apr; 112(4):1121-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.